卵巢癌是妇科常见三大恶性肿瘤之一。由于缺乏有效的早期诊断方法,诊断时多为晚期,治愈率不到20%,死亡率居妇科恶性肿瘤首位。随着分子生物学研究方法的飞速发展,P53、HSP70基因在卵巢癌发生、预后及治疗中的研究日趋深入,生物学治疗作为肿瘤治疗的第四种模式日益受到重视。现? Ovarian cancer is one of the three most common malignant tumors in gynecology. Due to the lack of effective early diagnosis, diagnosis is mostly late, the cure rate of less than 20%, the mortality rate ranks first in gynecological malignancies. With the rapid development of molecular biology research methods, the research of P53 and HSP70 genes in the occurrence, prognosis and treatment of ovarian cancer is becoming more and more profound. As the fourth model of tumor treatment, biological therapy is paid more and more attention. Now?